Viewing Study NCT00001133


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2026-01-24 @ 7:43 PM
Study NCT ID: NCT00001133
Status: COMPLETED
Last Update Posted: 2021-11-01
First Post: 2000-01-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dose-Response Relationship, Drug View
None Drug Therapy, Combination View
None HIV Protease Inhibitors View
None Ritonavir View
None Indinavir View
None Anti-HIV Agents View
None Pharmacokinetics View
None Treatment Experienced View